Navigation Links
Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Date:9/13/2007

mistry from Pedro Henriquez Urena University, Santo Domingo, and her M.S. in Chemistry from West Virginia University.

About Cadence Pharmaceuticals

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, including intravenous acetaminophen for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% aqueous gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Forward-Looking Statements

Cadence cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. These forward-looking statements include statements regarding Cadence's expectations for achieving its clinical and regulatory objectives for its two product candidates, intravenous acetaminophen and Omigard. The inclusion of forward-looking statements should not be regarded as a representation by Cadence that any of its plans will be achieved. Actual results may differ materially from those included in this presentation due to the risks and uncertainties inherent in the company's business, including, without limitation: delays in the initiation or completion of enrollment in the company's ongoing or planned clinical trials; the adequacy of the clinical trial designs to support regulatory approvals in the stated indications or at all, and the possibility that additional clinical trials or preclinical studies may be required to support regulatory approvals; unexpected adverse side effects or inadequate therapeutic efficacy of Cadence's product candidates that could delay or prevent their regulatory approval or commercialization, result in recalls o
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Wisconsin IT association names Gee president, CEO
4. Quintessence Biosciences names new president
5. CDW names VP to handle Berbee merger
6. NimbleGen names CFO with capital-raising past
7. Cisco names Berbee a top partner of 2005
8. Cisco names Inacom most innovative partner
9. UW-Madison medical school names new dean
10. GE Healthcare names new CEO
11. Bruker AXS names new leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils ... using Tin Can API combined with its own ... a leading developer of training content and solutions ... , Tin Can API is a cost-effective ... trainers more accurately measure the Return on Education ...
(Date:5/21/2013)... a new study led by George Washington University ... nucleation of ice in small droplets is strongly ... at the nanoscale. The formation of ice at ... question whose answer also has important implications for ... crystallization of ice from supercooled water is generally ...
(Date:5/21/2013)... The congress of the ERA-EDTA ... the biggest congress in Europe ... are in Istanbul to share ... pioneering studies have been presented: / (1) ... VIA HEMODIALYSATE REDUCES ESA USE" By SFP-iron ...
(Date:5/21/2013)... Clinverse, Inc. , a ... trials, announced today it has formed a strategic ... ClinPay® FLS eClinical commerce platform aggregates data collected ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship product, ... reporting transfer of value at investigator meetings or ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... (OTC Bulletin Board: BSTC), a biopharmaceutical company,developing first ... Thomas Wegman, will present at the upcoming Piper,Jaffray ... 2, 2008, at,4:30pm ET at the New York ... A live webcast ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... District of New Jersey last night granted AstraZeneca Pharmaceuticals, ... of Teva,s generic Pulmicort Respules(R) (budesonide inhaled solution). ... agreed and that it too would halt all sales ...
... Inc.,(Nasdaq: NBIX ) announced today that Kevin ... be presenting at the 20th,Annual Piper Jaffray Health Care ... The live "fireside chat" presentation takes place ... /10:30 a.m. Pacific Time (PT). The,presentation will be simultaneously ...
Cached Biology Technology:Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... Michigan Water Center today awarded 12 research grants, ... and protection efforts. , The two-year grants of ... efforts to track the remediation of harmful algae ... non-native weedy plant invasions; study chromosomal damage in ... restoration activities. , The grants were awarded to ...
(Date:5/21/2013)... an uphill battle? Try staying fit in space, where ... and bone. , That,s the challenge a group of ... three-year, $1.2 million grant from NASA. Their goal is ... missions. , "You could give astronauts the best exercise ... to stick to it, it isn,t going to help," ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Fueling fitness on the final frontier 2
... risky for some,breastfeeding mothers, according to researchers at The ... Children (SickKids) in Toronto.,Lead author Dr. Gideon Koren published ... which suggests that the codeine used in some ... fatal results for infants when ingested by some breastfeeding ...
... NH Embracing the belief that an interdisciplinary and ... advancing science and influencing policy, a group of experts ... how mercury moves through the marine ecosystem and into ... Metals Research Program convened the group of 43 leading ...
... protect people from heart attacks. But to do that they ... Earlier this year, a team led by William Maisel at ... be used to modify wireless communications from a pacemaker ( ... these signals to monitor and adjust the implanted device, but ...
Cached Biology News:Codeine not safe for all breastfeeding moms and their babies 2Dartmouth workshop sets research agenda for environmental mercury 2How to stop a new type of heart attack 2
...
... The CopyControl™ PCR Cloning Kits are designed to ... ensure that all PCR products, regardless of sequence ... All PCR products including those that are difficult ... that may be unstable or code for potentially ...
... 40 reactions. Optimized for the rapid ... products with blunt or sticky ends.Replaces ... consistently better signal-to-noise ratios and as ... generated by proof-reading thermostable polymerases are ...
Antibodies were affinity purified using epitopes specific to XLF immobilized on solid support....
Biology Products: